Navigation Links
Replidyne Provides Strategic Update
Date:12/10/2007

- Initiatives include restructuring and pipeline prioritization -

LOUISVILLE, Colo., Dec. 10 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN) today announced an operational restructuring to align critical resources with strategic priorities. These priorities include identifying a partner for Replidyne's late-stage antibiotic, faropenem medoxomil (faropenem), advancing and expanding its infectious disease pipeline, and exploring additional corporate development opportunities.

The key elements of the Company's operating strategy going forward are as follows:

-- Corporate restructuring. To better align the organization with its

strategic and operations priorities, Replidyne has reduced headcount by

approximately 35 percent, primarily in the administrative, clinical,

regulatory, and commercial functions.

-- Pipeline programs. Replidyne will retain key research and development

expertise to progress its most promising preclinical programs,

including REP3123, its investigational antibacterial for the treatment

of C. difficile-associated disease (CDAD), and its DNA replication

inhibition program. As a result of prioritizing these preclinical

programs, Replidyne has suspended the development of topical antibiotic

REP8839 due to the additional investment required to optimize the

formulation and the niche market opportunity.

-- Development strategy for faropenem. Replidyne will continue its ongoing

placebo-controlled Phase III trial for faropenem in acute exacerbation

of chronic bronchitis (AECB). This clinical trial is approaching

50 percent enrollment and results are expected in 200
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
2. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
3. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
4. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
5. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Raptor Pharmaceuticals Provides Update of Product Programs
8. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
9. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
10. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2008)...ency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, ...euticals,Corporation (TSX: NVN) today presented po...prietary Toll-like Receptor 3 agonist, Poly IC-Pol...ss 2008 in Lyon, France.,Study results demonstrate...ng the Toll-like Receptor 3 (TLR3) pathway. Data s...
(Date:10/8/2008)... clinical improvement in patients with pulmonary ...atment options have limited benefit for this debil...ood vessel disease, -- Imatinib mesylate, avail...ancers, known to inhibit protein associated with P... imatinib mesylate in PAH in 2009 EAST HANOV...
(Date:10/7/2008)...wswire/ -- McLaren Health Care and its Great,Lakes...s leading medical,minds to share the latest work u...tinal cancer treatments. The October 11th symposiu...Laren,s Sukamal Saha, M.D., an,award-winning surgi... for,colorectal cancer has gained worldwide recogn...
(Date:10/7/2008)...ewswire/ -- The Texas Cardiac Arrhythmia,Institute...ected as one of,only a few sites in the nation to ...a new device to treat persistent atrial fibrillati... research center specializing in heart,rhythm diso...l Center and,Texas Cardiovascular Consultants., "...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 1Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 1BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 2BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 4New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 1New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 2New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 3UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 1UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 2UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 3
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...Health Minister on the prescription issue. Under t...cribe in Wales. The move has been widely criticize...tion. "GPC Wales welcomes the statement of the H...rse and pharmacist prescribing in Wales. Doctors a...
...ochrane Collaboration (International private organ...rom various clinical trials) reviewed data from ov... and treatment. // The researchers found that th...uenza were not found to be effective now, some dru...
...ths due to medical errors are on the rise. Medical...n given on the drug labels. Food and Drug Administ...ght section //thereby making it easy for the docto...fore they could assess a drug as completely safe f...
...the twilight zone between life and death help the .... Dr Hasan Alam, a trauma surgeon at Massachusett...tails of this method. //In this method the surgeon...patients and perform the surgery. After the compl...
Other Medicine News:Health News:New Rule Results In The Complete Makeover In The Field Of Drug Advertising 2
Flattened Blunt Tip, Angled; 13mm from angle to tip; 3mm "U" shape tip; overall length excluding hub 28mm; in stainless steel.
Set of Five, Long, with side port; all approximately 75mm in length; in Stainless Steel.
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel.
The only solution for in-line digital measurement
Medicine Products: